Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06784479 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Combination of Remimazolam and Propofol During Drug-induced Sleep Endoscopy

StatusActive, Not Recruiting
PhasePhase 4
SponsorDan Liu
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated February 24, 2026 (before its estimated March 1, 2026 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary endpoints: 4 to 1
    • Secondary endpoints: 5 to 7
    v3
  2. Primary completion date: Jun 1, 2025 to Mar 1, 2026v2 Show 4 more changesShow less
    • Trial status: Enrolling by Invitation to Active, Not Recruiting
    • Enrollment target: estimated 80 to confirmed 174
    • Study completion date: Aug 1, 2025 to Mar 1, 2026
    • Start date changed from estimate of Feb 1, 2025 to Mar 1, 2025
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Dan Liu
3 trials monitored
See all monitored trials
This study helps patients find the optimal sedation regimen in drug-induced sleep endoscopy
Trial Details
NCT Number NCT06784479
Lead Sponsor Dan Liu
Conditions
(from sponsor)		 Sedative Effect During Drug-induced Sleep Endoscopy, Obstructive Sleep Apnea (OSA)
Related terms Sleep Apnea, Obstructive
Enrollment 174 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov